Epicurrents—an open-source web browser application for clinical neurophysiology education and scientific research

Clinical neurophysiology examinations include electroencephalography, sleep and vigilance studies, as well as nerve ...

FDA proposes new system for approving customized drugs and therapies for rare diseases

The FDA guidelines aim to create a new pathway for bespoke therapies due to the challenges of conducting large studies.

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals ...
Hosted on MSN

FDA’s commissioner vouchers prompt questions about award process

In June 2025, the US Food and Drug Administration (FDA) announced the Commissioner's National Priority Voucher (CNPV) pilot programme. The regulatory framework allows biotechs and pharma companies who ...
MarketWatch

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market

Shares of Thermo Fisher Scientific Inc. TMO shed 2.61% to $592.16 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA ...
American Enterprise Institute

The Genesis Mission: America’s Catch-Up Moment in Scientific AI

On November 24, the Trump administration launched the Genesis Mission, directing the Department of Energy (DOE) to build an integrated AI platform for scientific discovery. The initiative deserves ...
Seeking Alpha

Palvella Therapeutics Announces Scientific Publication in Clinical and Experimental Dermatology Highlighting a Systematic Review of Real-World Statin Evidence and Persistent ...

WAYNE, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (PVLA) (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and ...